Amit Kumar Mitra (Amit Mitra, Amit K Mitra)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Blood cancer journal

Cancers

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

Auburn University - Harrison School of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Auburn University - Harrison School of Pharmacy Oct 01 2017

United States

ASSISTANT PROFESSOR :: DRUG DISCOVERY AND DEVELOPMENT

Celgene Corp

United States

Senior Scientist :: Translational Development

University of Minnesota

United States

Assistant Professor (Research) :: Genetics, Cell Biology and Development

Publications

Taraswi Mitra Ghosh, Suman Mazumder, Joshua T Davis, Jyoti Yadav, Ayuba Akinpelu, Ahmed S Alnaim, Harish Kumar, Razan Waliagha, Allison E Church Bird, Soroush Rais-Bahrami, R Curtis Bird, Panagiotis Mistriotis, Amarjit Mishra, Clayton C Yates, Amit Kumar Mitra, Robert D Arnold
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. Cancer research communications 3 (7) (2023)
Joshua T Davis, Taraswi Mitra Ghosh, Suman Mazumder, Amit Kumar Mitra, Richard Curtis Bird, Robert D Arnold
Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. International journal of molecular sciences 24 (10) (2023)
Linda B Baughn, Erik Jessen, Neeraj Sharma, Hongwei Tang, James B Smadbeck, Mark D Long, Kathryn Pearce, Matthew Smith, Surendra Dasari, Zohar Sachs, Michael A Linden, Joselle Madonna Cook, A Keith Stewart, Marta Chesi, Amit Kumar Mitra, Peter Leif Bergsagel, Brian G Van Ness, Shaji K Kumar
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma. Blood cancer journal 13 (1) (2023)
Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji K Kumar, Benjamin A Bates, Noha Sharafeldin, Umit Topaloglu, null null
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma. Blood cancer journal 13 (1) (2023)
Suman Mazumder, Taraswi Mitra Ghosh, Ujjal K Mukherjee, Sayak Chakravarti, Farshad Amiri, Razan S Waliagha, Farnaz Hemmati, Panagiotis Mistriotis, Salsabil Ahmed, Isra Elhussin, Ahmad-Bin Salam, Windy Dean-Colomb, Clayton C Yates, Robert D Arnold, Amit Kumar Mitra
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers 14 (23) (2022)
Suman Mazumder, Taraswi Mitra Ghosh, Ujjal K Mukherjee, Sayak Chakravarti, Farshad Amiri, Razan S Waliagha, Farnaz Hemmati, Panagiotis Mistriotis, Salsabil Ahmed, Isra Elhussin, Ahmad-Bin Salam, Windy Dean-Colomb, Clayton C Yates, Robert D Arnold, Amit Kumar Mitra
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers 14 (23) (2022)
Harish Kumar, Suman Mazumder, Sayak Chakravarti, Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji K Kumar, Linda B Baughn, Brian G Van Ness, Amit Kumar Mitra
secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics. Blood cancer journal 12 (3) (2022)
Suman Mazumder, Taraswi Mitra Ghosh, Ujjal K Mukherjee, Sayak Chakravarti, Farshad Amiri, Razan S Waliagha, Farnaz Hemmati, Panagiotis Mistriotis, Salsabil Ahmed, Isra Elhussin, Ahmad-Bin Salam, Windy Dean-Colomb, Clayton C Yates, Robert D Arnold, Amit Kumar Mitra
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers 14 (23) (2022)
Abdelrahman H Elsayed, Xueyuan Cao, Amit Kumar Mitra, Huiyun Wu, Susana Raimondi, Christopher R Cogle, Zeina A Al-Mansour, Raul C Ribeiro, Alan S Gamis, Edward Anders Kolb, Richard Aplenc, Todd A Alonzo, Soheil Meshinchi, Jeffrey E Rubnitz, Stanley Pounds, Jatinder Kaur Lamba
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (7) (2022)
Qianqian Song, Benjamin A Bates, Yu Raymond Shao, Fang-Chi Hsu, Feifan Liu, Vithal Madhira, Amit Kumar Mitra, Timothy Bergquist, Ramakanth Kavuluru, Xiaochun Li, Noha Sharafeldin, Jing Su, Umit Topaloglu
Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Amit Kumar Mitra, Harish Kumar, Vijay Ramakrishnan, Li Chen, Linda Baughn, Shaji K Kumar, Sundararajan Vincent Rajkumar, Brian G Van Ness
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma. Blood cancer journal 10 (7) (2020)

Amit Kumar Mitra.css-eqlu8i{font-size:small;padding-left:4px;} (Amit Mitra, Amit K Mitra)

Publication Activity (10 Years)

Top Topics

Top Venues

Amit Kumar Mitra (Amit Mitra, Amit K Mitra)